
Sign up to save your podcasts
Or


For the first time, drugs targeting amyloid plaques have moved beyond trials and into real world use. Treatments like Kisunla and Leqembi, approved in 2023 and 2024, have helped validate the long debated amyloid theory.
10 alarming statistics about dementia care in the UK
Learn why setting up a Power of Attorney early is crucial for dementia care. We explain POAs, court orders, and how to protect your loved one’s future.
Learn Professor Gill Livingston’s 10 practical tips to reduce dementia risk — small daily habits that make a big difference for brain health.
Chris Long was the first patient at MUSC Health to receive the Alzheimer’s drug, Leqembi. Eighteen months on, he’s still golfing, spending time with friends, and feeling hopeful about the future. In this episode, Harvey shares Chris’s story, what his wife and doctors have observed, and the important facts to know if you’re considering this new treatment.
Turning Pain into Purpose: Helen McDavitt’s Story
From the publisher's feed